Shiho Asaka Selected Research

SGI 1776

4/2022

PIM1 is a Poor Prognostic Factor for and Potential Therapeutic Target in Serous Carcinoma of the Endometrium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiho Asaka Research Topics

Disease

12	Neoplasms (Cancer) 04/2022 - 12/2015
7	Adenocarcinoma 02/2022 - 01/2014
6	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2017
3	Hyperplasia 10/2020 - 09/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2018 - 01/2017
2	Immunoglobulin G4-Related Disease 07/2021 - 12/2020
2	Metaplasia 01/2021 - 09/2019
2	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 01/2019
2	Edema (Dropsy) 03/2017 - 01/2017
1	Liver Neoplasms (Liver Cancer) 04/2022
1	Cholangiocarcinoma 04/2022
1	Colorectal Neoplasms (Colorectal Cancer) 02/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Hyponatremia 01/2022
1	Inappropriate ADH Syndrome (SIADH) 01/2022
1	Castleman Disease (Castleman's Disease) 07/2021
1	Autoimmune Pancreatitis 12/2020
1	Papillomavirus Infections 10/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Genomic Instability 01/2019
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2018
1	Pleural Effusion (Pleural Effusions) 06/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017
1	Thrombocytopenia (Thrombopenia) 03/2017
1	Renal Insufficiency (Renal Failure) 03/2017
1	Fibrosis (Cirrhosis) 03/2017
1	Fever (Fevers) 03/2017
1	Hematuria 01/2017
1	Proteinuria 01/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017
1	Emphysema 01/2017
1	Mycosis Fungoides 01/2017
1	Pancreatic Intraductal Neoplasms 12/2015
1	Hemolysis 01/2014
1	Adenocarcinoma in Situ 01/2014

Drug/Important Bio-Agent (IBA)

3	ErbB Receptors (EGF Receptor)IBA 06/2018 - 02/2017
2	Biological ProductsIBA 02/2022 - 09/2019
2	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2019
2	MucinsIBA 09/2018 - 12/2015
2	Tyrosine Kinase InhibitorsIBA 06/2018 - 02/2018
1	SGI 1776IBA 04/2022
1	RNA (Ribonucleic Acid)IBA 04/2022
1	Messenger RNA (mRNA)IBA 04/2022
1	Leucine (L-Leucine)FDA Link 02/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2022
1	ClaudinsIBA 02/2022
1	Cadherins (E-Cadherin)IBA 02/2022
1	Vasopressins (Vasopressin)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 07/2021
1	Sucrase (Sucrose alpha-D-Glucohydrolase)IBA 01/2021
1	Oligo-1,6-Glucosidase (Isomaltase)IBA 01/2021
1	Combined Antibody TherapeuticsIBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	CB-839IBA 10/2020
1	olaparibIBA 10/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2020
1	AntioxidantsIBA 10/2020
1	EnzymesIBA 10/2020
1	GlutaminaseIBA 10/2020
1	Glutamine (L-Glutamine)FDA Link 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	NucleotidesIBA 10/2020
1	PlatinumIBA 10/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Proline (L-Proline)FDA Link 09/2019
1	Odorant Receptors (Odorant Receptor)IBA 09/2019
1	Retroelements (Retrotransposon)IBA 01/2019
1	AcetylglucosamineIBA 01/2019
1	ElementsIBA 01/2019
1	Mucin-6IBA 01/2019
1	Staphylococcal Protein A (Protein A)IBA 01/2019
1	Trefoil FactorsIBA 01/2019
1	Gastric MucinsIBA 01/2019
1	Polysaccharides (Glycans)IBA 09/2018
1	Cell-Free Nucleic AcidsIBA 06/2018
1	Growth Factor ReceptorsIBA 02/2018
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017
1	Reticulin (Reticular Fiber)IBA 03/2017
1	Serum AlbuminIBA 01/2017
1	cyclopropapyrroloindoleIBA 01/2017
1	Carcinoembryonic AntigenIBA 01/2017
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2017
1	Immunoglobulin A (IgA)IBA 01/2017
1	N 30IBA 01/2014

Therapy/Procedure

5	Therapeutics 10/2020 - 02/2017
4	Drug Therapy (Chemotherapy) 10/2020 - 01/2017
2	Hysterectomy 10/2020 - 01/2019
1	Oral Administration 04/2022
1	Thoracotomy 01/2022
1	Conservative Treatment 10/2020
1	Radiotherapy 10/2019
1	Immunotherapy 01/2019
1	Pancreaticoduodenectomy 12/2015
1	Bioprosthesis 01/2014
1	Thoracoscopes 12/2013